Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BET BRD Assay from US Patent US20240226096: "TREATMENT OF MYELOPROLIFERATIVE DISEASES AND DISORDERS WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN"
Assay data:14 Active, 4 Activity ≤ 1 nM, 14 Activity ≤ 1 µM, 14 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
In Vitro BRD4 (BD2) Enzymatic Activity Assay from US Patent US12030880: "Iminosulfanone compound as bromodomain protein inhibitor and pharmaceutical composition and medical use thereof"
Assay data:21 Active, 15 Activity ≤ 1 nM, 21 Activity ≤ 1 µM, 21 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
In Vitro BRD4 (BD1) Enzymatic Activity Assay from US Patent US12030880: "Iminosulfanone compound as bromodomain protein inhibitor and pharmaceutical composition and medical use thereof"
Assay data:21 Active, 2 Activity ≤ 1 nM, 21 Activity ≤ 1 µM, 21 Tested
In Vitro Enzymatic Activity Assay from US Patent US20240101551: "CRYSTAL FORM AND SALT FORM OF BROMINE DOMAIN PROTEIN INHIBITOR AND PREPARATION METHOD THEREFOR"
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 1 Tested
Inhibitory Action on Binding of BRD4 Protein and Ligand from US Patent US11890288: "Sulfonamide or sulfinamide compound having effect of inducing BRD4 protein degradation and pharmaceutical use thereof"
Assay data:3 Active, 3 Activity ≤ 1 µM, 3 Tested
BRD4 SGC Tm panel (DSF)
Assay data:1 Tested
SummaryRelated BioAssays by Target
Binding affinity to BRD4 bromodomain 2 (unknown origin) assessed as gibbs free energy change by ITC analysis
SummaryPubMed CitationRelated BioAssays by Target
Binding affinity to full length BRD4 short isoform (unknown origin) by BROMOscan assay
Assay data:2 Active, 1 Activity ≤ 1 µM, 4 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Binding affinity to human partial length BRD4 bromodomain 2 long isoform (K333 to E460 residues) expressed in bacterial expression system by BROMOscan assay
Assay data:2 Active, 4 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Binding affinity to BRD4 bromodomain 1/2 long isoform (unknown origin) by BROMOscan assay
Binding affinity to human partial length BRD4 bromodomain 1 long isoform (N44 to E168 residues) expressed in bacterial expression system by BROMOscan assay
Assay data:3 Active, 4 Tested
Binding affinity to BRD4 in human PC-9 cell lysate assessed as increase in thermal stabilization at 10 uM at 38 to 71 degreeC measured after 30 mins by CETSA
Binding affinity to BRD4 in human PC-9 cell lysate assessed as increase in thermal stabilization at 2 uM at 38 to 71 degreeC measured after 30 mins by CETSA
Displacement of biotinylated small-molecule ligand from recombinant His-tagged BRD4 bromodomain 2 (unknown origin) measured after 10 mins by TR-FRET assay
Assay data:4 Active, 11 Tested
Displacement of biotinylated small-molecule ligand from recombinant His-tagged BRD4 bromodomain 1 (unknown origin) measured after 10 mins by TR-FRET assay
Assay data:9 Active, 1 Activity ≤ 1 µM, 11 Tested
Protac activity at IAP/BRD4 in human SK-MEL-28 cells assessed as induction of BRD4 degradation at 0.1 to 10 uM measured after 24 hrs by Western blotting analysis
Assay data:2 Active, 2 Tested
Protac activity at VHL/BRD4 in human MCF7 cells assessed as induction of BRD4 degradation at 10 uM measured after 24 hrs by Western blotting analysis
Assay data:1 Active, 2 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on